NICOLETTI, FERDINANDO
 Distribuzione geografica
Continente #
NA - Nord America 10.644
EU - Europa 5.254
AS - Asia 3.557
SA - Sud America 636
AF - Africa 543
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 16
Totale 20.669
Nazione #
US - Stati Uniti d'America 10.209
SG - Singapore 1.978
IT - Italia 1.406
IE - Irlanda 1.367
CN - Cina 1.298
UA - Ucraina 1.239
BR - Brasile 594
CA - Canada 408
RU - Federazione Russa 348
CI - Costa d'Avorio 301
DE - Germania 289
SE - Svezia 216
SN - Senegal 181
GB - Regno Unito 60
FR - Francia 56
IN - India 51
VN - Vietnam 50
CH - Svizzera 36
EE - Estonia 36
UZ - Uzbekistan 36
AT - Austria 29
IR - Iran 29
NL - Olanda 28
BE - Belgio 23
BG - Bulgaria 23
PL - Polonia 23
MX - Messico 19
GR - Grecia 18
NG - Nigeria 18
FI - Finlandia 17
IQ - Iraq 16
AU - Australia 15
EU - Europa 15
TR - Turchia 15
AR - Argentina 13
HK - Hong Kong 12
JP - Giappone 12
EC - Ecuador 11
ZA - Sudafrica 11
LB - Libano 10
MA - Marocco 10
BD - Bangladesh 9
RO - Romania 9
GE - Georgia 8
TN - Tunisia 6
EG - Egitto 5
HU - Ungheria 5
PK - Pakistan 5
VE - Venezuela 5
IL - Israele 4
JO - Giordania 4
NZ - Nuova Zelanda 4
PT - Portogallo 4
AE - Emirati Arabi Uniti 3
CL - Cile 3
CO - Colombia 3
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
ET - Etiopia 3
MK - Macedonia 3
PE - Perù 3
PY - Paraguay 3
AO - Angola 2
BA - Bosnia-Erzegovina 2
KE - Kenya 2
KH - Cambogia 2
KR - Corea 2
LI - Liechtenstein 2
MD - Moldavia 2
NP - Nepal 2
SK - Slovacchia (Repubblica Slovacca) 2
SY - Repubblica araba siriana 2
AL - Albania 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CY - Cipro 1
ES - Italia 1
GH - Ghana 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
ID - Indonesia 1
JM - Giamaica 1
KG - Kirghizistan 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LT - Lituania 1
LU - Lussemburgo 1
MY - Malesia 1
NO - Norvegia 1
PA - Panama 1
PH - Filippine 1
RS - Serbia 1
SV - El Salvador 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 20.669
Città #
Santa Clara 1.703
Jacksonville 1.471
Dublin 1.365
Chandler 1.322
Singapore 1.069
Boardman 651
Chicago 489
Catania 443
Lawrence 379
Cambridge 376
Andover 370
Nanjing 365
Toronto 326
Abidjan 301
Houston 297
Ashburn 228
Des Moines 226
San Mateo 197
Dakar 181
Civitanova Marche 169
Wilmington 148
Nanchang 129
Grafing 125
Hebei 97
Saint Petersburg 92
Council Bluffs 82
Jiaxing 81
Ottawa 79
Shenyang 77
The Dalles 66
Tianjin 64
Changsha 62
São Paulo 52
Bremen 46
Dong Ket 46
Los Angeles 40
Moscow 38
Rome 38
Palermo 36
Beijing 34
Falls Church 33
Hefei 31
Milan 28
Guangzhou 27
Hangzhou 27
Munich 27
Norwalk 27
Seattle 25
Brussels 23
Messina 23
Washington 23
Nizza di Sicilia 22
Pune 22
Jinan 21
Kunming 20
Sant'Antonio Abate 20
Vercelli 20
Abuja 18
Dearborn 18
Rio de Janeiro 18
Acireale 17
Belo Horizonte 17
Den Haag 17
Tappahannock 17
Ardabil 16
Leawood 16
Ningbo 16
Augusta 15
Liberty Lake 15
San Francisco 15
Zhengzhou 13
Ann Arbor 12
Mascalucia 12
Monmouth Junction 12
Curitiba 11
Florence 11
Frankfurt Am Main 11
Licata 11
Mountain View 11
Ragusa 11
Shanghai 11
Amsterdam 10
Chiaramonte Gulfi 10
Maletto 10
Mumbai 10
Redwood City 10
Vienna 10
Lausanne 9
Melbourne 9
New York 9
Porto Alegre 9
Vicenza 9
Brasília 8
Hanover 8
Padova 8
Puerto Juárez 8
Salvador 8
Santa Teresa Di Riva 8
Tashkent 8
Tbilisi 8
Totale 14.289
Nome #
Analysis of interleukin (IL)-1beta IL-1 receptor antagonist, soluble IL-1 receptor type II and IL-1 accessory protein in HCV-associated lymphoproliferative disorders 300
The role of macrophages in neuroinflammatory and neurodegenerative pathways of alzheimer’s disease, amyotrophic lateral sclerosis, and multiple sclerosis: Pathogenetic cellular effectors and potential therapeutic targets 202
Differential modulation and prognostic values of immune-escape genes in uveal melanoma 148
KCNMA1 Expression is Downregulated in Colorectal Cancer via Epigenetic Mechanisms 126
Gasotransmitters and the immune system: Mode of action and novel therapeutic targets 106
Pathogenic role for macrophage migration inhibitory factor in glioblastoma and its targeting with specific inhibitors as novel tailored therapeutic approach. 102
Emerging Raf inhibitors 94
The H2S Donor GYY4137 Stimulates Reactive Oxygen Species Generation in BV2 Cells While Suppressing the Secretion of TNF and Nitric Oxide 92
Association of chitotriosidase genotype with the development of non-alcoholic fatty liver disease 89
β-amyloid-activated cell cycle in SH-SY5Y neuroblastoma cells: Correlation with the MAP kinase pathway 88
Emerging role of the macrophage migration inhibitory factor family of cytokines in neuroblastoma. Pathogenic effectors and novel therapeutic targets? 88
CD3+CD25+ cells, CD3+CD4+/CD3+CD8+ ratio, HLA alloantigen association and ICA in type 1 (insulin-dependent) diabetes 87
The antitumor properties of a nontoxic, nitric oxide-modified version of saquinavir are independent of Akt 86
Identification of novel chemotherapeutic strategies for metastatic uveal melanoma 86
Ageing: from inflammation to cancer. 86
Endotoxin-induced lethality in neonatal mice is counteracted by interleukin-10 (IL-10) and exacerbated by anti-IL-10 86
CORRELATION BETWEEN ISLET CELL ANTIBODIES AND ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES IN HEALTHY 1ST-DEGREE RELATIVES OF TYPE-1 (INSULIN-DEPENDENT) DIABETIC-PATIENTS 85
Anti-inflammatory and immune regulatory properties of 5-androsten-3 beta,17 beta-diol (HE2100), and synthetic analogue HE3204 implications for treatment of autoimmune diseases 84
Induction of OAS gene family in HIV monocyte infected patients with high and low viral load. 84
Characterization of Altered Molecular Pathways in the Entorhinal Cortex of Alzheimer's Disease Patients and In Silico Prediction of Potential Repurposable Drugs 83
Chronic administration of UK-114, a multifunctional emerging protein, modulates the Th1/Th2 cytokine pattern and experimental autoimmune diseases 81
Akt as a therapeutic target in cancer 81
Androstene Hormones as regulators of Inflammation: role of Regulatory T Cells 80
Acquired Immune Resistance Follows Complete Tumor Regression without Loss of Target Antigens or IFNγ Signaling. 80
Saquinavir-NO inhibits S6 kinase activity, impairs secretion of the encephalytogenic cytokines interleukin-17 and interferon-gamma and ameliorates experimental autoimmune encephalomyelitis 79
The antineoplastic drug flavopiridol reverses memory impairment induced by Amyloid-ß1-42 oligomers in mice 78
Exploratory analysis of iPSCS-derived neuronal cells as predictors of diagnosis and treatment of Alzheimer disease 77
Cognitive decline in rheumatoid arthritis: Insight into the molecular pathogenetic mechanisms 77
Critical Roles of EGFR Family Members in Breast Cancer and Breast Cancer Stem Cells: Targets for Therapy 76
Identification of CD4+ T cell biomarkers for predicting the response of patients with relapsing-remitting multiple sclerosis to natalizumab treatment 76
Acceleration of SLE-like syndrome development in NZBxNZW F1 mice by beta-glucan. 75
Computational modeling of PI3K/AKT and MAPK signaling pathways in melanoma cancer 75
16alpha-Bromoepiandrosterone (HE2000) limits non-productive inflammation and stimulates immunity in lungs 75
Cyclin D1 and Ewing's sarcoma/PNET: A microarray analysis. 74
Emerging therapeutic targets for the treatment of hepatic fibrosis 74
Identification of novel targets for the diagnosis and treatment of liver fibrosis. 74
Prevention of spontaneous autoimmune diabetes in NOD mice by transferring in vitro antigen-pulsed syngeneic dendritic cells 73
Advances in targeting signal transduction pathways. 73
Androsteneidiol ameliorates experimental autoimmune encephalomyelitis in mice and may limit relapses in patients with multiple sclerosis 73
Anti-angiogenic Therapy in Cancer: Downsides and New Pivots for Precision Medicine 73
Involvement of the Nrf2/HO-1/CO axis and therapeutic intervention with the CO-Releasing Molecule CORM-A1, in a murine model of Autoimmune Hepatitis 73
Characterization of the pathophysiological role of CD47 in uveal melanoma 73
Impaired expression of tetraspanin 32 (TSPAN32) in memory T cells of patients with multiple sclerosis 73
Prophylaxis with the novel immunomodulator pidotimod reduces the frequency and severity of upper respiratory tract infections in children with Down's syndrome 72
Apotransferrin inhibits interleukin-2 expression and protects mice from experimental autoimmune encephalomyelitis 72
Comparative study of rapamycin and temsirolimus demonstrate superimposable anti-tumor potency on prostate cancer cells 72
Anticancer and differentiation properties of the nitric oxide derivative of lopinavir in human glioblastoma cells 72
Vitamin D3: a helpful immuno-modulator 71
Amelioration of experimental allergic neuritis by sodium fusidate (fusidin): Suppression of IFN-gamma and TNF-alpha and enhancement of IL-10 71
A potent immunomodulatory compound, (S,R)-3-phenyl-4,5-dihydro-5-isoxasole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice 71
Emerging MEK inhibitors 71
Association of t(14;18) translocation with HCV infection in gastrointestinal MALT lymphomas 70
Preclinical evaluation of the PI3K/Akt/mTOR pathway in animal models of multiple sclerosis 70
Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo 70
Ectopic NGAL expression can alter sensitivity of breast cancer cells to EGFR, Bcl-2, CaM-K inhibitors and the plant natural product berberine 69
Immunobiology of Uveal Melanoma: State of the Art and Therapeutic Targets 69
A Network Medicine Approach for Drug Repurposing in Duchenne Muscular Dystrophy 68
Endogenous interleukin-12 only plays a key pathogenetic role in non-obese diabetic mouse diabetes during the very early stages of the disease 68
Anti-melanoma potential of nitric oxide modified form of HIV inhibitor-saquinavir; cell specific mode of drug action 68
Use of uk114 in the treatment of leishmaniasis 68
CD4+T-cell gene expression of healthy donors, HIV-1 and elite controllers: Immunological chaos 68
Prediction of PD‐l1 expression in neuroblastoma via computational modeling 68
Curative effects of sodium fusidate on the development of dinitrobenzenesulfonic acid-induced colitis in rats 67
Inhibition of human immunodeficiency virus (HIV-1) infection in human peripheral blood leucocytes-SCID reconstituted mice by rapamycin 67
Induction of caspase - independent apoptotic-like cell death of mouse mammary tumor TA3Ha cells in vitro and reduction of their lethality in vivo by the novel chemotherapeutic agent GIT-27NO 67
EFFECTS OF OCTREOTIDE ON THE GLYCEMIC LEVELS IN INSULIN-DEPENDENT DIABETIC-PATIENTS - COMPARATIVE-STUDY BETWEEN ADMINISTRATION THROUGH MULTIPLE SUBCUTANEOUS INJECTIONS AND CONTINUOUS SUBCUTANEOUS INFUSION 67
Evaluation of hyaluronic acid-P40 conjugated cream in a mouse model of dermatitis induced by oxazolone 67
Contribution of the macrophage migration inhibitory factor superfamily of cytokines in the pathogenesis of preclinical and human multiple sclerosis: In silico and in vivo evidences 67
Aberrant Expression of MHC Class II in Melanoma Attracts Inflammatory Tumor-Specific CD4+ T- Cells, Which Dampen CD8+ T-cell Antitumor Reactivity. 67
Epilepsy and multiple sclerosis 66
An imidazoline compound completely counteracts interleukin-1 [beta] toxic effects to rat pancreatic islet [beta] cells 66
Failure of exogenously administered interferon-gamma or blockage of endogenous interleukin-4 with specific inhibitors to augment the incidence of autoiimune diabetes in male NOD mice 66
Erratic expression of DNA polymerases by beta-amyloid causes neuronal death 66
Comparative Study of Rapamycin and Temsirolimus Demonstrates Superimposable Anti-Tumour Potency on Prostate Cancer Cells 66
Cyclin D1 in pediatric neuroblastic tumors: A microarray analysis 66
Decitabine induces regulatory T cells, inhibits the production of IFN-gamma and IL-17 and exerts preventive and therapeutic efficacy in rodent experimental autoimmune neuritis 66
Computational Analysis of Pathogenetic Pathways in Alzheimer's Disease and Prediction of Potential Therapeutic Drugs 65
Exogenous type-1 cytokines modulate mercury-induced hyper-IgE in the rat 65
Sodium fucidate (fusidin) ameliorates the course of monophasic experimantal allergic encephalomyelitis in the Lewis rat 65
HE3286, an orally bioavailable synthetic analogue of an active DHEA metabolite suppresses spontaneous autoimmune diabetes in the non-obese diabetic (NOD) mouse 65
Increased rate of survial in streptococcus pneumoniae -infected rats treated with the new immunomodulator pitotimod 65
Unique antineoplastic profile of Saquinavir-NO, a novel NO-derivative of the protease inhibitor Saquinavir, on the in vitro and in vivo tumor formation of A375 human melanoma cells 65
Effects of octreotide on glycaemic control, glucose disposal, hepatic glucose production and counterregulatory hormones secretion in type 1 and type 2 insulin treated diabetic patients 65
The analysis of IL-1 beta and its naturally occurring inhibitors in multiple sclerosis: The elevation of IL-1 receptor antagonist and IL-1 receptor type II after steroid therapy 65
5-androstenediol ameliorates pleurisy, septic shock, and experimental autoimmune encephalomyelitis in mice. 65
Prevention of clinical and histological signs of MOG-induced experimental allergic encephalomyelitis by prolonged treatment with recombinant human EGF 65
Chitotriosidase and inflammatory mediator levels in Alzheimer's disease and cerebrovascular dementia 64
Essential pathogenic role of endogenous IL-18 in murine diabetes induced by multiple low doses of streptozotocin. Prevention of hyperglycemia and insulitis by a recombinant IL-18-binding protein: FC construct 64
Antibodies to endothelial cells in primary vasculitides mediate in vitro endothelial cytotoxicity in the presence of normal peripheral blood mononuclear cells 64
A dual mechanism of neuroprotection by transforming growth factor-β1 against β-amyloid neurotoxicity 64
Modulation of heat shock proteins during macrophage differentiation. 64
ANTICYTOMEGALOVIRUS IGM AND IGG ANTIBODIES, ISLET CELL ANTIBODIES AND GAMMA-INTERFERON SERUM LEVELS IN NEWLY DIAGNOSED IDDM PATIENTS 64
Senescence as a main mechanism of Ritonavir and Ritonavir-NO action against melanoma 64
Effect of octreotide on blood glucose and counterregulatory hormones in insulin-dependent diabetic patients: The role of dose and route of administration 63
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway 63
Antibiotic susceptibility of group A streptococci in 2 Italian cities: Milano and Catania 63
Effects of Tumour Necrosis Factor-alpha on Human Sperm Motility and Apoptosis 62
Hypomethylating agent 5-aza-2 ′-deoxycytidine (DAC) ameliorates multiple sclerosis in mouse models 62
BRAF inhibition improves tumor recognition by the immune system: Potential implications for combinatorial therapies against melanoma involving adoptive T-cell transfer 62
In vivo treatment with a monoclonal antibody to interferon-gamma neither affects the survival nor the incidence of lupus-nephritis in the MRL/lpr-lpr mouse 62
Totale 7.739
Categoria #
all - tutte 84.909
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.909


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020382 0 0 0 0 0 0 0 0 0 0 263 119
2020/20212.357 25 195 297 25 581 54 296 11 306 15 423 129
2021/20222.810 326 381 4 55 436 57 398 93 252 8 71 729
2022/20234.352 408 153 55 373 423 798 19 768 1.059 60 129 107
2023/20241.778 118 245 87 170 65 392 12 120 10 75 280 204
2024/20256.422 64 1.084 469 301 1.743 648 228 348 574 748 215 0
Totale 21.229